Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Sientra Awarded $50,000 Contract By U.S. Army: Breast Tissue & Implants

Sientra Awarded $50,000 Contract By U.S. Army: Breast Tissue & Implants

https://sam.gov/opp/904db8ba4adc43dd998c531bf397b64e/view

byCharles Gross

February 14, 2023

1 minute read

https://sam.gov/opp/904db8ba4adc43dd998c531bf397b64e/view

Chevron Removes Staff From US Gulf Of Mexico Oil Platforms Amid Hurricane Idalia Concerns: Report

By Nabaparna Bhattacharya

August 30, 8:27 AM

Chevron Corporation (NYSE: CVX) has reportedly evacuated staff from three U.S. Gulf of Mexico oil production platforms to protect from Hurricane Idalia.

CVX

Over $11M In Ethereum Shorts Liquidated As Valkyrie ETH ETF Futures Gain Approval

By Mehab Qureshi

September 28, 11:16 PM

Valkyrie Investments has emerged victorious in offering the first-ever exchange-traded fund (ETF) featuring Ethereum (CRYPTO: ETH) futures.

ETH

News

A Look Into Basic Materials Sector Value Stocks

By Benzinga Insights

December 1, 10:38 AM

Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies…

ALB

HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $73

By Benzinga Newsdesk

July 1, 6:25 AM

HC Wainwright & Co. analyst Joseph Hafling maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $60 to $73.

CLDX

Sientra Awarded $50,000 Contract By U.S. Army: Breast Tissue & Implants

Related Posts

Chevron Removes Staff From US Gulf Of Mexico Oil Platforms Amid Hurricane Idalia Concerns: Report

Over $11M In Ethereum Shorts Liquidated As Valkyrie ETH ETF Futures Gain Approval

A Look Into Basic Materials Sector Value Stocks

HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $73